查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
歐洲微載體市場預測至 2030 年 - 區域分析 - 按產品、設備、應用和最終用戶
市場調查報告書
商品編碼
1494455

歐洲微載體市場預測至 2030 年 - 區域分析 - 按產品、設備、應用和最終用戶

Europe Microcarriers Market Forecast to 2030 - Regional Analysis - by Product, Equipment, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 101 Pages | 訂單完成後即時交付

價格

歐洲微載體市場預計將從2022年的4.1719億美元成長到2030年的10.3552億美元。

微載體製造商的策略性舉措和創新產品推動歐洲微載體市場

在微載體市場營運的公司專注於策略發展，例如合作、擴張、協議、夥伴關係和新產品發布，這有助於他們提高銷售額、擴大地理覆蓋範圍並增強能力，以滿足比現有客戶群更大的需求。提到了微載體市場的一些值得注意的發展，2023年10月，可樂麗有限公司開發了用於再生醫學細胞培養的PVA水凝膠微載體。該產品計劃於 2024 年 1 月在日本和海外推出，首先從美國推出。 2023 年 6 月，帝人前沿推出了新型非織造微載體，可實現快速、大規模、高品質的細胞培養。新型非織造微載體結合了帝人前沿的專有纖維工藝和非織造設計技術，以及日本福井大學工程學院的纖維相關生物醫學專業知識。 2023 年 10 月，Semarion 推出了 SemaCyte 微載體平台的早期採用者計畫。 Semarion 開發的 SemaCytes 是利用微晶片製造技術、奈米磁性和智慧材料創建的細胞載體材料。這些分析微載體是扁平的，具有超小型磁控孔的功能，可將貼壁細胞的小集落帶入懸浮液中，以改善基於細胞的實驗。 2021 年 1 月，賽默飛世爾科技公司收購了 Groupe Novasep SAS 旗下位於比利時的病毒載體製造業 Henogen SA。 Henogen 為生物技術公司和大型生物製藥客戶提供疫苗和治療藥物製造服務。透過此次收購，賽默飛世爾科技擴大了在細胞和基因疫苗及療法領域的能力。 2020年11月，新加坡-麻省理工學院科技聯盟（SMART）的研究人員開發了一種用於大規模細胞生產和細胞擴增的新型微載體。使用這種微載體將使企業能夠以比傳統方法更具成本效益的方式獲得更高的產量，同時減少細胞修復過程中涉及的步驟數量。 SMART 新開發的可溶性明膠微載體可用於細胞擴增，以治療各種疾病，包括骨和軟骨缺陷以及移植物抗宿主疾病，即對外來骨髓和細胞的排斥。因此，推出PVA水凝膠微載體、非織造微載體和SemaCyte微載體平台等產品，並透過合作和夥伴關係啟動新業務以維持市場競爭力，將為微載體市場創造重大成長機會。

歐洲微載體市場概況

歐洲在全球微載體市場中佔有重要佔有率。該地區的市場成長歸因於發達的醫療保健產業和基礎設施，以及德國、英國、法國、羅馬尼亞和葡萄牙等經濟體的醫療保健支出顯著較高。為了提高生物製藥生產力，對細胞培養設備的進步的需求不斷成長，並且不斷進行具有可靠結果的研究，從而催生了自動化細胞培養過程和系統。此外，合約製造和研究設施正在大規模營運，以滿足歐洲醫療保健產業對先進治療方案不斷成長的需求。德國的製藥業由中小企業組成；在全球製藥工業規模最大的國家中排名第四。根據國際貿易管理局 (ITA) 的數據，2019 年德國醫藥市場規模約為 625 億美元。該行業的成長是由研發投資增加和專利申請數量增加等因素所推動的。 Paul-Ehrlich-Institut (PEI) 聯邦疫苗和生物醫學產品研究所在流感疫苗進入德國市場之前對其進行批量測試。德國擁有強大的製藥業，尤其注重研發。根據 NecstGen 的報告，2021 年德國正在進行超過 29 項評估 CAR 修飾免疫細胞的活躍臨床試驗，其中大部分生產涉及 CAR-T 細胞。此外，迄今為止，德國已開展了 50 多項基因療法臨床研究。

歐洲微載體市場營收及 2030 年預測（百萬美元）

歐洲微載體市場細分

歐洲微載體市場分為產品、設備、應用、最終用戶和國家。

根據產品，歐洲微載體市場分為微載體珠和培養基和試劑。 2022 年，微載體珠細分市場在歐洲微載體市場中佔有更大佔有率。

在設備方面，歐洲微載體市場分為生物反應器、培養容器等。 2022 年，生物反應器領域佔據歐洲微載體市場的最大佔有率。

根據應用，歐洲微載體市場分為生物製藥生產、細胞和基因治療、組織工程和再生醫學等。到2022年，生物製藥生產領域在歐洲微載體市場中佔據最大佔有率。

根據最終用戶，歐洲微載體市場分為製藥和生物技術公司、合約研究組織和合約製造組織以及學術和研究機構。 2022 年，製藥和生物技術公司領域佔據歐洲微載體市場的最大佔有率。

根據國家/地區，歐洲微載體市場分為德國、英國、法國、義大利、西班牙和歐洲其他地區。 2022 年，德國在歐洲微載體市場佔據主導地位。

Teijin Ltd、Bio-Rad Laboratories Inc、denovoMATRIX GmbH、Sartorius AG、Danaher Corp、Corning Inc、Eppendorf SE、Percell Biolytica AB、Asahi Kasei Corp 和 Polysciences Inc 是歐洲微載體市場上的一些領先公司。

目錄

第 1 章：簡介

第 2 章：執行摘要

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：歐洲微載體市場 - 主要產業動態

  • 主要市場促進因素：
    • 隨著癌症和傳染病發病率的上升，對細胞療法的需求
    • 外包細胞和基因治療製造越來越受歡迎
    • 再生醫學的採用激增
  • 市場限制
    • 生物製劑和細胞療法的高成本
  • 市場機會
    • 微載體製造商的策略性舉措和創新產品
  • 未來的趨勢
    • 細胞和基因治療製造服務的自動化
  • 影響分析

第 5 章：微載體市場 - 歐洲市場分析

  • 微載體市場收入，2022 - 2030

第 6 章：歐洲微載體市場 - 收入和 2030 年預測 - 按產品

  • 概述
  • 2022 年和 2030 年按產品分類的微載體市場收入佔有率 (%)
  • 微載體珠
  • 介質和試劑

第 7 章：歐洲微載體市場 - 收入和 2030 年預測 - 按設備

  • 概述
  • 2022 年及 2030 年按設備分類的微載體市場收入佔有率 (%)
  • 生物反應器
  • 培養容器
  • 其他

第 8 章：歐洲微載體市場 - 2030 年收入和預測 - 按應用

  • 概述
  • 2022 年和 2030 年按應用分類的微載體市場收入佔有率 (%)
  • 生物製藥生產
  • 細胞和基因治療
  • 組織工程與再生醫學
  • 其他

第 9 章：歐洲微載體市場收入和 2030 年預測 - 最終用戶

  • 概述
  • 歐洲微載體最終用戶市場佔有率 - 2022 年和 2030 年 (%)
  • 製藥和生物技術公司
    • 概述
    • 製藥和生物技術公司：微載體市場 - 收入和 2030 年預測
  • 合約研究組織和合約製造組織
    • 概述
    • 合約研究組織和合約製造組織：微載體市場 - 收入和 2028 年預測
  • 學術及研究機構
    • 概述
    • 學術和研究機構：微載體市場 - 收入和 2028 年預測

第 10 章：歐洲微載體市場收入和 2030 年預測 - 國家分析

    • 歐洲
      • 德國
      • 英國
      • 法國
      • 義大利
      • 西班牙
      • 歐洲其他地區

第 11 章：微載體市場-產業格局

  • 概述
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第 12 章：公司簡介

  • Teijin Ltd
  • Bio-Rad Laboratories Inc
  • denovoMATRIX GmbH
  • Sartorius AG
  • Danaher Corp
  • Corning Inc
  • Eppendorf SE
  • Percell Biolytica AB
  • Asahi Kasei Corp
  • Polysciences Inc

第 13 章：附錄

Product Code: BMIRE00029977

The Europe microcarriers market is expected to grow from US$ 417.19 million in 2022 to US$ 1,035.52 million by 2030. It is estimated to record a CAGR of 12.0% from 2022 to 2030.

Strategic Initiatives and Innovative Products by Microcarrier Manufacturers Drive Europe Microcarriers Market

Companies operating in the microcarriers market focus on strategic developments such as collaborations, expansions, agreements, partnerships, and new product launches, which help them improve their sales, expand their geographic reach, and enhance their capacities to cater to a larger than existing customer base. A few of the noteworthy developments in the microcarriers market are mentioned, In October 2023, Kuraray Co., Ltd. developed PVA hydrogel microcarriers for cell cultures used in regenerative medicine. The product is scheduled for launch in January 2024 in Japan and overseas, beginning in the US. In June 2023, Teijin Frontier introduced new nonwoven microcarriers that enable speedy, large-scale, high-quality cell culture. The new nonwoven microcarriers combine Teijin Frontier's proprietary fiber process and nonwoven design technology, and fiber-related biomedical expertise by the Faculty of Engineering, University of Fukui, Japan. In October 2023, Semarion, unveiled the Early Adopter Programme for its SemaCyte Microcarrier Platform. SemaCytes developed by Semarion are cell carrier materials created using microchip fabrication technologies, nanomagnetism, and smart materials. These assaying microcarriers are flat and function as ultraminiaturized, magnetically steerable wells that carry small colonies of adherent cells into suspension to improve cell-based experiments. In January 2021, Thermo Fisher Scientific Inc acquired Henogen S.A., a Belgium-based viral vector manufacturing business of Groupe Novasep SAS. Henogen provides vaccine and therapeutics manufacturing services to biotechnology companies and large biopharmaceutical customers. With this acquisition, Thermo Fisher Scientific expanded its capabilities in the cell and gene vaccines and therapies category. In November 2020, researchers from the Singapore-MIT Alliance for Science and Technology (SMART) developed a novel microcarrier for large-scale cell production and cell expansion. Employing this microcarrier would allow businesses to have higher yields in a more cost-effective way than traditional methods while lowering the number of steps involved in the cell retrieval process. This newly developed dissolvable Gelatin microcarrier from SMART can be used in cell expansion for treating various ailments, including bone and cartilage defects, and graft vs. host disease, i.e., the rejection of foreign bone marrow and cells. Therefore, introducing products such as PVA hydrogel microcarriers, nonwoven microcarriers, and SemaCyte microcarrier platform, and the initiation of new businesses through collaborations and partnerships to remain competitive in the market would create significant growth opportunities in the microcarriers market.

Europe Microcarriers Market Overview

Europe holds a significant share of the global microcarrier market. The market growth in this region is attributed to the well-developed healthcare sector and infrastructure, and the significantly high healthcare spending in economies such as Germany, the UK, France, Romania, and Portugal. The increasing demand for advancements in cell culture equipment for better biopharmaceutical productivity and ongoing research with reliable outcomes are resulting in automated cell culture processes and systems. In addition, contract manufacturing and research facilities are operating on huge scales to meet the ever-increasing demands of the European healthcare sector for advanced treatment options. The pharmaceutical industry in Germany consists of small and mid-sized companies; it ranks fourth among the countries with the largest pharmaceutical industries in the world. As per the International Trade Administration (ITA), the pharmaceutical market in Germany accounted for ~US$ 62.5 billion in 2019. The country is most likely to remain one of the most desirable destinations for the global pharmaceutical industries over the coming years in terms of manufacturing and supply. The industry's growth is driven by factors such as increasing investments in R&D and the elevating number of patent applications. The Federal Institute for Vaccines and Biomedical Products at Paul-Ehrlich-Institut (PEI) conducts the batch testing of influenza vaccines before their release into the German market. Germany has a strong pharmaceutical industry with a notable R&D focus. As per a NecstGen report, more than 29 active clinical trials evaluating CAR-modified immune cells were underway in Germany in 2021, and the majority of the production involved CAR-T cells. Also, over 50 clinical studies have been conducted in gene therapy in Germany so far.

Europe Microcarriers Market Revenue and Forecast to 2030 (US$ Million)

Europe Microcarriers Market Segmentation

The Europe microcarriers market is segmented into product, equipment, application, end user, and country.

Based on product, the Europe microcarriers market is bifurcated into microcarriers beads and media & reagents. The microcarriers beads segment held a larger share of the Europe microcarriers market in 2022.

In terms of equipment, the Europe microcarriers market is segmented into bioreactors, culture vessels, and others. The bioreactors segment held the largest share of the Europe microcarriers market in 2022.

Based on application, the Europe microcarriers market is segmented into biopharmaceutical production, cell and gene therapy, tissue engineering and regenerative medicine, and other. The biopharmaceutical production segment held the largest share of the Europe microcarriers market in 2022. Further, biopharmaceutical production segment is categorized into therapeutic protein production and vaccine production.

Based on end user, the Europe microcarriers market is segmented into pharmaceutical & biotechnology companies, contract research organizations & contract manufacturing organizations, and academic & research institutes. The pharmaceutical & biotechnology companies segment held the largest share of the Europe microcarriers market in 2022.

Based on country, the Europe microcarriers market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe microcarriers market in 2022.

Teijin Ltd, Bio-Rad Laboratories Inc, denovoMATRIX GmbH, Sartorius AG, Danaher Corp, Corning Inc, Eppendorf SE, Percell Biolytica AB, Asahi Kasei Corp, and Polysciences Inc are some of the leading companies operating in the Europe microcarriers market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Microcarriers Market - Key Industry Dynamics

  • 4.1 Key Market Drivers:
    • 4.1.1 Need for Cell Therapies with Rising Incidence of Cancer and Infectious Diseases
    • 4.1.2 Increasing Popularity of Outsourcing Cell and Gene Therapy Manufacturing
    • 4.1.3 Surge in Adoption of Regenerative Medicine
  • 4.2 Market Restraints
    • 4.2.1 High Cost of Biologics and Cell-based Therapies
  • 4.3 Market Opportunities
    • 4.3.1 Strategic Initiatives and Innovative Products by Microcarrier Manufacturers
  • 4.4 Future Trends
    • 4.4.1 Automation of Cell and Gene Therapy Manufacturing Services
  • 4.5 Impact Analysis

5. Microcarriers Market - Europe Market Analysis

  • 5.1 Microcarriers Market Revenue (US$ Mn), 2022 - 2030

6. Europe Microcarriers Market - Revenue and Forecast to 2030 - by Product

  • 6.1 Overview
  • 6.2 Microcarriers Market Revenue Share, by Product 2022 & 2030 (%)
  • 6.3 Microcarrier Beads
    • 6.3.1 Overview
    • 6.3.2 Microcarrier Beads: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Media and Reagents
    • 6.4.1 Overview
    • 6.4.2 Media and Reagents: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Microcarriers Market - Revenue and Forecast to 2030 - by Equipment

  • 7.1 Overview
  • 7.2 Microcarriers Market Revenue Share, by Equipment 2022 & 2030 (%)
  • 7.3 Bioreactors
    • 7.3.1 Overview
    • 7.3.2 Bioreactors: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Culture Vessels
    • 7.4.1 Overview
    • 7.4.2 Culture Vessels: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Microcarriers Market - Revenue and Forecast to 2030 - by Application

  • 8.1 Overview
  • 8.2 Microcarriers Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Biopharmaceutical Production
    • 8.3.1 Overview
    • 8.3.2 Biopharmaceutical Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
    • 8.3.3 Therapeutic Protein Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
    • 8.3.4 Vaccine Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Cell and Gene Therapy
    • 8.4.1 Overview
    • 8.4.2 Cell and Gene Therapy: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Tissue Engineering and Regenerative Medicine
    • 8.5.1 Overview
    • 8.5.2 Tissue Engineering and Regenerative Medicine: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Microcarriers Market Revenue and Forecasts To 2030 - End User

  • 9.1 Overview
  • 9.2 Europe Microcarriers Market Share by End User - 2022 & 2030 (%)
  • 9.3 Pharmaceutical and Biotechnology Companies
    • 9.3.1 Overview
    • 9.3.2 Pharmaceutical and Biotechnology Companies: Microcarriers Market- Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Contract Research Organizations and Contract Manufacturing Organizations
    • 9.4.1 Overview
    • 9.4.2 Contract Research Organizations and Contract Manufacturing Organizations: Microcarriers Market- Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Academic and Research Institutes
    • 9.5.1 Overview
    • 9.5.2 Academic and Research Institutes: Microcarriers Market- Revenue and Forecast to 2028 (US$ Million)

10. Europe Microcarriers Market Revenue and Forecasts to 2030 - Country Analysis

  • 10.1 Europe Microcarriers Market, Revenue and Forecast To 2030
    • 10.1.1 Overview
    • 10.1.2 Europe: Microcarriers Market, by Country
      • 10.1.2.1 Germany
        • 10.1.2.1.1 Overview
        • 10.1.2.1.2 Germany: Microcarriers Market Revenue and Forecast to 2030 (GERMANY$ Mn)
        • 10.1.2.1.3 Germany: Microcarriers Market, by Product
        • 10.1.2.1.4 Germany: Microcarriers Market, by Equipment
        • 10.1.2.1.5 Germany: Microcarriers Market, by Application
        • 10.1.2.1.5.1 Germany: Microcarriers Market, by Biopharmaceutical Production
        • 10.1.2.1.6 Germany: Microcarriers Market, by End User
      • 10.1.2.2 UK
        • 10.1.2.2.1 Overview
        • 10.1.2.2.2 UK: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.2.3 UK: Microcarriers Market, by Product
        • 10.1.2.2.4 UK: Microcarriers Market, by Equipment
        • 10.1.2.2.5 UK: Microcarriers Market, by Application
        • 10.1.2.2.5.1 UK: Microcarriers Market, by Biopharmaceutical Production
        • 10.1.2.2.6 UK: Microcarriers Market, by End User
      • 10.1.2.3 France
        • 10.1.2.3.1 Overview
        • 10.1.2.3.2 France: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.3.3 France: Microcarriers Market, by Product
        • 10.1.2.3.4 France: Microcarriers Market, by Equipment
        • 10.1.2.3.5 France: Microcarriers Market, by Application
        • 10.1.2.3.5.1 France: Microcarriers Market, by Biopharmaceutical Production
        • 10.1.2.3.6 France: Microcarriers Market, by End User
      • 10.1.2.4 Italy
        • 10.1.2.4.1 Overview
        • 10.1.2.4.2 Italy: Microcarriers Market Revenue and Forecast to 2030 (ITALY$ Mn)
        • 10.1.2.4.3 Italy: Microcarriers Market, by Product
        • 10.1.2.4.4 Italy: Microcarriers Market, by Equipment
        • 10.1.2.4.5 Italy: Microcarriers Market, by Application
        • 10.1.2.4.5.1 Italy: Microcarriers Market, by Biopharmaceutical Production
        • 10.1.2.4.6 Italy: Microcarriers Market, by End User
      • 10.1.2.5 Spain
        • 10.1.2.5.1 Overview
        • 10.1.2.5.2 Spain: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.5.3 Spain: Microcarriers Market, by Product
        • 10.1.2.5.4 Spain: Microcarriers Market, by Equipment
        • 10.1.2.5.5 Spain: Microcarriers Market, by Application
        • 10.1.2.5.5.1 Spain: Microcarriers Market, by Biopharmaceutical Production
        • 10.1.2.5.6 Spain: Microcarriers Market, by End User
      • 10.1.2.6 Rest of Europe
        • 10.1.2.6.1 Overview
        • 10.1.2.6.2 Rest of Europe: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.6.3 Rest of Europe: Microcarriers Market, by Product
        • 10.1.2.6.4 Rest of Europe: Microcarriers Market, by Equipment
        • 10.1.2.6.5 Rest of Europe: Microcarriers Market, by Application
        • 10.1.2.6.5.1 Rest of Europe: Microcarriers Market, by Biopharmaceutical Production
        • 10.1.2.6.6 Rest of Europe: Microcarriers Market, by End User

11. Microcarriers Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Organic Growth Strategies
    • 11.2.1 Overview
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview

12. Company Profiles

  • 12.1 Teijin Ltd
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Bio-Rad Laboratories Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 denovoMATRIX GmbH
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Sartorius AG
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Danaher Corp
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Corning Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Eppendorf SE
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Percell Biolytica AB
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Asahi Kasei Corp
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Polysciences Inc
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About the Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Microcarriers Market Segmentation
  • Table 2. Germany Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 3. Germany Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 4. Germany Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 5. Germany Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 6. Germany: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 7. UK Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 8. UK Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 9. UK Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 10. UK Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 11. UK: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 12. France Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 13. France Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 14. France Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 15. France Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 16. France: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 17. Italy Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 18. Italy Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 19. Italy Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 20. Italy Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 21. Italy: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 22. Spain Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 23. Spain Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 24. Spain Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 25. Spain Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 26. Spain: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 27. Rest of Europe Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 28. Rest of Europe Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 29. Rest of Europe Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 30. Rest of Europe Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 31. Rest of Europe: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 32. Recent Organic Growth Strategies in Microcarriers Market
  • Table 33. Recent Inorganic Growth Strategies in the Microcarriers Market
  • Table 34. Glossary of Terms

List Of Figures

  • Figure 1. Microcarriers Market Segmentation, By Country
  • Figure 2. Key Insights
  • Figure 3. Microcarriers Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints for Microcarriers Market
  • Figure 5. Microcarriers Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. Microcarriers Market Revenue Share, by Product 2022 & 2030 (%)
  • Figure 7. Microcarrier Beads: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Media and Reagents: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Microcarriers Market Revenue Share, by Equipment 2022 & 2030 (%)
  • Figure 10. Bioreactors: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Culture Vessels: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Microcarriers Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 14. Biopharmaceutical Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Therapeutic Protein Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Vaccine Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Cell and Gene Therapy: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Tissue Engineering and Regenerative Medicine: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Europe Microcarriers Market Share by End User - 2022 & 2030 (%)
  • Figure 21. Pharmaceutical and Biotechnology Companies: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
  • Figure 22. Contract Research Organizations and Contract Manufacturing Organizations: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
  • Figure 23. Academic and Research Institutes: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
  • Figure 24. Microcarriers Market, 2022 (US$Mn)
  • Figure 25. Europe: Microcarriers Market, By Countries, 2022 And 2030 (%)
  • Figure 26. Germany: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. UK: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 28. France: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 29. Italy: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 30. Spain: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 31. Rest of Europe: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)